LCBiot-IEEQAKTFLDKFNHEAEDLFYQS-NH2

Ref. 3D-PP48842

Informations sur le produit

• Nom: LCBiot-IEEQAKTFLDKFNHEAEDLFYQS-NH2

Description

Peptide LCBiot-IEEQAKTFLDKFNHEAEDLFYQS-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-IEEQAKTFLDKFNHEAEDLFYQS-NH2 include the following: Advances in magnetic microbead affinity selection screening: Discovery of natural ligands to the SARS-CoV-2 spike protein RN Muchiri , J Kibitel, MA Redick - Journal of the , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jasms.1c00318 Cannabinoids block cellular entry of SARS-CoV-2 and the emerging variants RB van Breemen , RN Muchiri , TA Bates - Journal of natural , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.1c00946 SARS-CoV-2 entry inhibitors: Small molecules and peptides targeting virus or host cells R Cannalire , I Stefanelli, C Cerchia , AR Beccari - International journal of , 2020 - mdpi.comhttps://www.mdpi.com/1422-0067/21/16/5707 SARS-CoV-2 spike protein capture by peptide functionalized networks MS Rahman , CWH Rajawasam - Journal of Polymer , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pol.20220539 Antiviral fibrils of self-assembled peptides with tunable compositions J Dodd-o, A Roy , Z Siddiqui , R Jafari , F Coppola - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41467-024-45193-3 Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD G Zhang , S Pomplun , AR Loftis, X Tan , A Loas - biorxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.03.19.999318.abstract Identification of Putative Cell-entry-inhibitory Peptides against SARS-CoV-2 from Edible Insects: An in silico Study FC Wong , JH Ong , TT Chai - EFood, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.2991/efood.k.200918.002 approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV B Ucar , T Acar , PP Arayici , S Derman - Nanotechnology, 2021 - iopscience.iop.orghttps://iopscience.iop.org/article/10.1088/1361-6528/ac1c22/meta Computational Design of Potential Binder Protein for SARS-CoV-2 Spike RBD through A Novel Deep Neural Network Based-Protein Outpainting Algorithm B Duan, Y Sun - The Fifth International Conference on Biological , 2021 - dl.acm.orghttps://dl.acm.org/doi/abs/10.1145/3469678.3469685 Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches A Monti , L Vitagliano , A Caporale, M Ruvo - International Journal of , 2023 - mdpi.comhttps://www.mdpi.com/1422-0067/24/9/7842

• Marque: Biosynth